“Mitch Steiner’s Veru Inc. is impacting the world with its compelling data in reducing death in moderate to severe, hospitalized COVID patients treated with its lead compound, sabazabulin, and its located right here in Miami”
Company Spotlight Event
Company in the Spotlight: Veru, Inc.
Date: May 10, 2022
Watch the presentation of how the Veru team imagined and then executed on their novel approach to COVID 19 mortality.
On May 10, 2022, Miami Medicos, in co-sponsorship with HomeOffs, hosted its first ever “Company Spotlight” event highlighting Veru Inc. and its transformational CEO, Dr. Mitch Steiner, in Miami. The event gave us the opportunity to hear the story of Veru’s lead drug candidate, sabizabulin, that showed a 55% reduction in deaths compared with placebo in moderate to severe patients hospitalized for COVID-19.
“If this new drug had been available at the beginning of the COVID pandemic, of the 1,000,000 Americans who’ve died, 550,000 would be home with their families this evening”
Mitchell Steiner, MD, FACS
Vice Chairman and CFO, Miami Medicos
Mitchell Steiner, MD, FACS has served as President and Chief Executive Officer of Veru and as a director of the Company since October 2016. Dr. Steiner was the co-founder of Aspen Park.